David P. Kelsen

Memorial Sloan Kettering Cancer Center

Full Professor(heuristic)

Gastric Cancer Management and Outcomes · Pulmonary and Respiratory Medicine

h-index87

i10-index233

Publications493

Citations22,965

Grants

No NSF/NIH grants on record.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0017

PageRank within Pulmonary and Respiratory Medicine co-authorship network

Explore collaboration map

Admission Signals

New paper: Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case report (Frontiers in Oncology)2025-12-18
New preprint: Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial2025-09-01

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0001-6139-438X

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 12 of 12

Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case report
Frontiers in Oncology · 2025-12-18
Clinico-genomic Characterization of PALB2-Mutated Pancreatic Adenocarcinoma
International Journal of Cancer Care and Delivery · 2025-09-26
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialPreprint
Research Square · 2025-09-01 · 3 citations
Clinico-genomic characterization of <i>PALB2</i> -mutated pancreatic adenocarcinoma.
Journal of Clinical Oncology · 2025-05-28
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
The Oncologist · 2025-05-01 · 11 citations
Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2
Cell · 2025-02-11 · 49 citations
Multimodal Treatment in Locally Advanced Esophageal Adenocarcinoma — Two Interventions Better Than Three?
New England Journal of Medicine · 2025-01-22 · 2 citations
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Nature Medicine · 2025-01-03 · 71 citations
708 Chemoimmunotherapy (ChemoIO) as treatment for pancreatic neuroendocrine carcinoma: survival outcomes and immunogenomic analysis
Regular and Young Investigator Award Abstracts · 2024-11-01
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort
JNCI Journal of the National Cancer Institute · 2024-10-26 · 3 citations
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
JAMA Oncology · 2024-09-05 · 20 citations
1504MO Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
Annals of Oncology · 2024-09-01 · 7 citations

Open author page on OpenAlex →